Filtros de búsqueda

Lista de obras de Sabina Signoretti

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

artículo científico publicado en 2016

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis

artículo científico publicado en 2019

A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model.

artículo científico publicado en 2018

A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes

artículo científico publicado en 2021

A Working Group Classification of Focal Prostate Atrophy Lesions

article

A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer

artículo científico publicado en 2013

A constitutively activated form of the p110beta isoform of PI3-kinase induces prostatic intraepithelial neoplasia in mice

artículo científico publicado en 2010

A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma

artículo científico publicado en 2019

A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis

scientific article published on 04 February 2014

A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis.

artículo científico publicado en 2014

A phase 1 study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor-targeted therapies

artículo científico publicado en 2016

A phase III randomized study comparing perioperative nivolumab vs. observation in patients with localized renal cell carcinoma undergoing nephrectomy (PROSPER RCC)

A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression

artículo científico publicado en 2008

Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib

artículo científico publicado en 2014

Adult Renal Cell Carcinoma: A Review of Established Entities from Morphology to Molecular Genetics

artículo científico publicado en 2015

An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer.

artículo científico publicado en 2018

Androgen-dependent regulation of Her-2/neu in prostate cancer cells

artículo científico publicado en 2006

Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells

artículo científico publicado en 2004

Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee ⬇️

artículo científico publicado el 22 de abril de 2013

Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal Cancer.

artículo científico publicado en 2015

Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion

artículo científico publicado en 2005

Associations of Fc gamma receptor (FcgR2a, FcgR3a and FcgR2c) genotype with outcome in metastatic renal cell carcinoma (mRCC) patients receiving high dose interleukin 2 (HD-IL2).

artículo científico publicado en 2015

Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer

artículo científico publicado en 2020

Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase

artículo científico publicado en 2018

BRAF mutations in metanephric adenoma of the kidney

artículo científico publicado en 2012

Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations

artículo científico publicado en 2016

Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity

artículo científico publicado en 2017

Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy

artículo científico publicado en 2010

Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: analysis from the treatment approaches in renal cancer global evaluation trial (TARGET).

artículo científico publicado en 2012

Carbonic anhydrase IX as a predictive biomarker of response to kidney cancer therapy

artículo científico publicado en 2008

Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade

artículo científico publicado en 2010

Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer

artículo científico publicado en 2005

Cell kinetic studies fail to identify sequentially proliferating progenitors as the major source of epithelial renewal in the adult murine prostate

artículo científico publicado en 2015

Cells Lacking the RB1 Tumor Suppressor Gene are Hyperdependent on Aurora B Kinase for Survival

article

Chimeric antigen receptor T cells secreting anti-PD-L1 antibodies more effectively regress renal cell carcinoma in a humanized mouse model

scientific article published on 29 April 2016

Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation.

artículo científico publicado en 2016

Combination of radiofrequency ablation with antiangiogenic therapy for tumor ablation efficacy: study in mice

artículo científico publicado en 2007

Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accumulation and coagulation in multiple tissues and tumor types in animals

artículo científico publicado en 2005

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

artículo científico

Comprehensive Characterization of Cancer Driver Genes and Mutations

article

Comprehensive Genomic Profiling of Metastatic Tumors in a Phase 2 Biomarker Study of Everolimus in Advanced Renal Cell Carcinoma

artículo científico publicado en 2018

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

artículo científico publicado en 2015

Comprehensive analyses of tumor immunity: implications for cancer immunotherapy

artículo científico publicado en 2016

Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial Carcinoma

artículo científico publicado en 2016

Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: results from COMPARZ, a randomized controlled trial

artículo científico publicado en 2014

Corrigendum: Essential roles of PI(3)K-p110β in cell growth, metabolism and tumorigenesis

artículo científico publicado en 2016

Corrigendum: Loss of LDAH associated with prostate cancer and hearing loss

artículo científico publicado en 2019

Defining cell lineages in the prostate epithelium

artículo científico publicado en 2006

Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors

artículo científico publicado en 2013

Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells

artículo científico publicado en 2002

Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma

artículo científico publicado en 2015

Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications

artículo científico publicado en 2017

Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expression

artículo científico publicado en 2017

Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms

artículo científico publicado en 2018

Do Liposomal Apoptotic Enhancers Increase Tumor Coagulation and End-Point Survival in Percutaneous Radiofrequency Ablation of Tumors in a Rat Tumor Model? ⬇️

artículo científico publicado el 21 de septiembre de 2010

Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model?

artículo científico publicado en 2009

Editor's Note: The Efficacy of the Novel Dual PI3-Kinase/mTOR Inhibitor NVP-BEZ235 Compared with Rapamycin in Renal Cell Carcinoma

scientific article published on 01 July 2019

Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-Line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma

artículo científico publicado en 2020

Efficacy of Savolitinib vs Sunitinib in Patients With MET-Driven Papillary Renal Cell Carcinoma: The SAVOIR Phase 3 Randomized Clinical Trial

artículo científico publicado en 2020

Efficacy of immune checkpoint inhibitors (ICI) and genomic characterization of sarcomatoid and/or rhabdoid (S/R) metastatic renal cell carcinoma (mRCC).

artículo científico publicado en 2019

Erratum: Corrigendum: High-throughput oncogene mutation profiling in human cancer

article

Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis

artículo científico publicado en 2008

Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell Carcinoma

artículo científico publicado en 2017

Expression of T-cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma

artículo científico publicado en 2020

FCGR Polymorphisms Influence Response to IL2 in Metastatic Renal Cell Carcinoma

artículo científico publicado en 2016

Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer

artículo científico publicado en 2009

FoxOs enforce a progression checkpoint to constrain mTORC1-activated renal tumorigenesis

artículo científico publicado en 2010

GRK3 is essential for metastatic cells and promotes prostate tumor progression

artículo científico publicado en 2014

Gene transcript quantitation by real-time RT-PCR in cells selected by immunohistochemistry-laser capture microdissection

artículo científico publicado en 2002

Genetic and Functional Studies Implicate HIF1α as a 14q Kidney Cancer Suppressor Gene ⬇️

artículo científico publicado el 7 de junio de 2011

Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

artículo científico publicado en 2015

Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors

artículo científico publicado en 2018

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma

artículo científico publicado en 2018

Genomic investigation of etiologic heterogeneity: methodologic challenges

artículo científico publicado en 2014

Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion

artículo científico publicado en 2011

Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line ⬇️

artículo científico publicado el 1 de enero de 2002

HIF activation causes synthetic lethality between the VHL tumor suppressor and the EZH1 histone methyltransferase.

artículo científico publicado en 2017

HIF-independent synthetic lethality between CDK4/6 inhibition and VHL loss across species

artículo científico publicado en 2019

High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma.

artículo científico publicado en 2011

High-throughput oncogene mutation profiling in human cancer

article

Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate

artículo científico publicado en 2019

Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo

artículo científico publicado en 2015

Hypoxia regulation of the cell cycle in malignant melanoma: putative role for the cyclin-dependent kinase inhibitor p27.

artículo científico publicado en 2004

Identification of ALK gene alterations in urothelial carcinoma

artículo científico publicado en 2014

Identification of CDCP1 as a hypoxia-inducible factor 2α (HIF-2α) target gene that is associated with survival in clear cell renal cell carcinoma patients

artículo científico publicado en 2013

Identification of Luminal Breast Cancers That Establish a Tumor-Supportive Macroenvironment Defined by Proangiogenic Platelets and Bone Marrow–Derived Cells ⬇️

artículo científico publicado el 15 de agosto de 2012

Immunohistochemical staining for BRAF V600E supports the diagnosis of metanephric adenoma

artículo científico publicado en 2015

Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models

artículo científico publicado en 2006

In Reply

Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma.

artículo científico publicado en 2016

Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference

artículo científico publicado en 2009

Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinoma.

artículo científico publicado en 2014

Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma (S/R RCC) to reveal potential determinants of poor prognosis and response to immune checkpoint inhibitors (ICI).

artículo científico publicado en 2020

Intermediate basal cells of the prostate: in vitro and in vivo characterization

artículo científico publicado en 2003

Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma

artículo científico publicado en 2020

KIR3DL3 is an inhibitory receptor for HHLA2 that mediates an alternative immunoinhibitory pathway to PD1

scientific article published on 23 November 2020

Killer immunoglobulin-like receptor (KIR) and KIR-ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2.

artículo científico publicado en 2016

LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer

artículo científico publicado en 2009

Landscape of tumor-infiltrating T cell repertoire of human cancers

artículo científico publicado en 2016

Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathways

artículo científico publicado en 2010

Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy ⬇️

artículo científico publicado el 23 de agosto de 2010

Loss of LDAH associated with prostate cancer and hearing loss

artículo científico publicado en 2018

Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation

artículo científico publicado en 2002

Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1

artículo científico publicado en 2011

MET as a target in papillary renal cell carcinoma

artículo científico publicado en 2014

Mammalian SWI/SNF complex genomic alterations and immune checkpoint blockade in solid tumors

scientific article published on 22 April 2020

Mechanisms of acquired resistance to rapalogs in metastatic renal cell carcinoma

scientific article published on 26 September 2018

Metabolomic adaptations and correlates of survival to immune checkpoint blockade

scientific article published on 25 September 2019

Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/- mice by the p85 regulatory subunits of phosphoinositide 3-kinase

artículo científico publicado en 2005

Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model

artículo científico publicado en 2017

Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma

scientific article published on 25 October 2019

Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma

artículo científico publicado en 2016

Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates

scientific article published on 12 May 2014

Obligate roles for p16(Ink4a) and p19(Arf)-p53 in the suppression of murine pancreatic neoplasia

artículo científico publicado en 2002

On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models

artículo científico publicado en 2016

Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer

artículo científico publicado en 2002

Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer

artículo científico publicado en 2016

Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer

Opposing Effects of Androgen Deprivation and Targeted Therapy on Prostate Cancer Prevention ⬇️

artículo científico publicado el 20 de diciembre de 2012

Orthotopic xenografts of RCC retain histological, immunophenotypic and genetic features of tumours in patients ⬇️

artículo científico publicado el 27 de junio de 2011

PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells

artículo científico publicado en 2015

PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUN

artículo científico publicado en 2019

Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine

artículo científico publicado en 2016

Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney

artículo científico publicado en 2009

Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapy

artículo científico publicado en 2008

Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma

artículo científico publicado en 2016

Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma.

artículo científico publicado en 2016

Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma

artículo científico publicado en 2015

Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A)

artículo científico publicado en 2022

Phase II study of nivolumab and salvage nivolumab + ipilimumab in treatment-naïve patients (pts) with advanced clear cell renal cell (HCRN GU16-260-Cohort A): Final report.

artículo científico publicado en 2022

Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor

artículo científico publicado en 2014

Pml represses tumour progression through inhibition of mTOR.

artículo científico publicado en 2011

Poor prognosis and advanced clinicopathological features of clear cell renal cell carcinoma (ccRCC) are associated with cytoplasmic subcellular localisation of Hypoxia inducible factor-2α.

artículo científico publicado en 2014

Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinoma

artículo científico publicado en 2007

Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma

scientific article published on 01 November 2020

Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study

artículo científico publicado en 2015

Progressive immune dysfunction with advancing disease stage in renal cell carcinoma

artículo científico publicado en 2021

RET protein expression in papillary renal cell carcinoma

artículo científico

RNA-seq reveals aurora kinase-driven mTOR pathway activation in patients with sarcomatoid metastatic renal cell carcinoma.

artículo científico publicado en 2014

Radiofrequency ablation combined with liposomal quercetin to increase tumour destruction by modulation of heat shock protein production in a small animal model ⬇️

artículo científico publicado el 1 de enero de 2011

Reciprocal effects of STAT5 and STAT3 in breast cancer

artículo científico publicado en 2009

Reduced tumor growth with combined radiofrequency ablation and radiation therapy in a rat breast tumor model

artículo científico publicado en 2005

Renal Cell Carcinoma in the Era of Precision Medicine: From Molecular Pathology to Tissue-Based Biomarkers

artículo científico publicado en 2018

Renal cancer resistance to antiangiogenic therapy is delayed by restoration of angiostatic signaling.

artículo científico publicado en 2010

Renal cell carcinoma

artículo científico publicado en 2017

Renal-cell carcinoma: a step closer to a new classification

artículo científico publicado en 2013

Resistance of renal cell carcinoma to sorafenib is mediated by potentially reversible gene expression

artículo científico publicado en 2011

Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features

artículo científico publicado en 2019

Risk of Bilateral Renal Cell Cancer

artículo científico publicado en 2009

SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression

artículo científico publicado en 2011

SQSTM1 is a pathogenic target of 5q copy number gains in kidney cancer

scientific article published on December 2013

Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study

artículo científico publicado en 2012

Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma

artículo científico publicado en 2014

Summary from the First Kidney Cancer Research Summit, September 12-13, 2019: A Focus on Translational Research

artículo científico publicado en 2020

Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis

artículo científico publicado en 2015

Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinoma

artículo científico publicado en 2018

Targeting lactate dehydrogenase--a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells.

artículo científico publicado en 2014

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

artículo científico publicado en 2018

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

article

The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma

artículo científico publicado en 2018

The Glomuvenous Malformation Protein Glomulin Binds Rbx1 and Regulates Cullin RING Ligase-Mediated Turnover of Fbw7 ⬇️

artículo científico publicado el 8 de marzo de 2012

The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesis

scientific article published on 14 November 2019

The UTX Tumor Suppressor Directly Senses Oxygen to Control Chromatin and Cell Fate

The efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 compared with rapamycin in renal cell carcinoma

artículo científico publicado en 2010

The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?

scientific article published on 10 April 2019

The high-dose aldesleukin "select" trial: a trial to prospectively validate predictive models of response to treatment in patients with metastatic renal cell carcinoma

artículo científico publicado en 2014

The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer

artículo científico publicado en 2004

The landscape of somatic copy-number alteration across human cancers

artículo científico publicado en 2010

The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinoma.

artículo científico publicado en 2013

The role of mammalian target of rapamycin inhibitors in the treatment of advanced renal cancer

artículo científico publicado en 2007

Tissue biomarkers in renal cell carcinoma: issues and solutions

artículo científico publicado en 2009

Tissue-based research in kidney cancer: current challenges and future directions

artículo científico publicado en 2008

Transgenic Expression of Polyomavirus Middle T Antigen in the Mouse Prostate Gives Rise to Carcinoma ⬇️

artículo científico publicado el 16 de marzo de 2011

Treatment selection for patients with metastatic renal cell carcinoma

artículo científico publicado en 2009

VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400.

artículo científico publicado en 2008

Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibition.

artículo científico publicado en 2014

Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development

artículo científico publicado en 2016

Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma

artículo científico publicado en 2016

Young investigator challenge: Application of cytologic techniques to circulating tumor cell specimens: Detecting activation of the oncogenic transcription factor STAT3.

artículo científico publicado en 2015

Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion

artículo científico publicado en 2013

irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial

scientific article published on 22 January 2019

p63 promotes cell survival through fatty acid synthase

artículo científico publicado en 2009

p63 regulates commitment to the prostate cell lineage

artículo científico publicado en 2005

p63-expressing cells are the stem cells of developing prostate, bladder, and colorectal epithelia ⬇️

artículo científico publicado el 25 de abril de 2013

pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent manner

artículo científico publicado en 2016

ΔNp63 (p40) expression in prostatic adenocarcinoma with diffuse p63 positivity

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda